Next Article in Journal
Evolutionary and Conservation Genetics
Previous Article in Journal
Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Planar EPID-Based Dosimetry for SRS and SRT Patient-Specific QA

1
Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, Thailand
2
Department of Radiation Oncology, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok 10210, Thailand
3
Department of Radiological Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand
4
Faculty of Health Science Technology, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok 10210, Thailand
*
Author to whom correspondence should be addressed.
Life 2021, 11(11), 1159; https://doi.org/10.3390/life11111159
Submission received: 8 July 2021 / Revised: 8 September 2021 / Accepted: 24 September 2021 / Published: 30 October 2021
(This article belongs to the Section Radiobiology and Nuclear Medicine)

Abstract

:
The study’s purpose was to develop and validate Electronic Portal Imaging Device (EPID)-based dosimetry for Stereotactic Radiosurgery (SRS) and Stereotactic Radiation Therapy (SRT) patient-specific Quality Assurance (QA). The co-operation between extended Source-to-Imager Distance (SID) to reduce the saturation effect and simplify the EPID-based dosimetry model was used to perform patient-specific QA in SRS and SRT plans. The four parameters were included for converting the image to dose at depth 10 cm; dose-response linearity with MU, beam profile correction, collimator scatter and water kernel. The model accuracy was validated with 10 SRS/SRT plans. The traditional diode arrays with MapCHECK were also used to perform patient-specific QA for assuring model accuracy. The 150 cm-SID was found a possibility to reduce the saturation effect. The result of model accuracy was found good agreement between our EPID-based dosimetry and TPS calculation with GPR more than 98% for gamma criteria of 3%/3 mm, more than 95% for gamma criteria of 2%/2 mm, and the results related to the measurement with MapCHECK. This study demonstrated the method to perform SRT and SRT patient-specific QA using EPID-based dosimetry in the FFF beam by co-operating between the extended SID that can reduce the saturation effect and estimate the planar dose distribution with the in-house model.

1. Introduction

In radiation therapy, advanced beam delivery techniques such as Intensity Modulated Radiation Therapy (IMRT) are developed to increase the radiation dose at a tumor and reduce radiation dose at normal organs simultaneously [1,2]. The comprehensive step, namely patient-specific Quality Assurance (QA), was required for the IMRT process to assure the dose agreement between treatment planning calculation and beam delivery. Many QA tools were used to measure the radiation for patient-specific QA, such as detector arrays (Delta4, Matrixxx, Octavious, etc.), Electronic Portal Imaging Device (EPID), film, gel dosimetry, and log file-based systems. Due to the small field used in Stereotactic Radiosurgery (SRS) and Stereotactic Radiation Therapy (SRT), the patient-specific QA requires a high-resolution detector to catch up the error. The conventional detector arrays with low resolution can significantly affect the QA with false-positive results [3]. The high-resolution QA tools such as film dosimetry, gel dosimetry, and film-class resolution digital detector were widely used for SRS patient-specific QA. However, the practical drawbacks of each QA tool have been reported, such as time-consuming film and gel [4,5] and the time required for setup and alignment of detector arrays [6]. EPID-based dosimetry is another choice for SRS patient-specific QA that is less time-consuming and does not require setup and tool alignment. Many researchers developed the algorithm for EPID-based dosimetry with different approaches [7,8,9,10,11]. However, the saturation effect has been reported [12,13,14,15] according to high dose rate measurement in flattening-filter-free (FFF) beams. FFF beams are generally used for treatment in cases of SRT, SRS, and Stereotactic Body Radiation Therapy (SBRT) which was required high dose rates to reduce the treatment time [16,17,18]. The saturation effect can be solved by providing the new Image Acquisition Systems (IAS) from the vendor to catch up the high dose rate [19], and many studies were developed the method to reduce the saturation effect. Tyner et al. [20] demonstrated the method to reduce the saturation effect by placing 1 cm of water-equivalent plastic on the EPID surface. Nicoli et al. [21] extended Source-to-Imager Distance (SID), and they found SID up to 150 cm was suitable to reduce saturation effect in FFF beams. Chuter et al. [22] adopted the extended SID method with 160 cm to reduce the saturation effect for a dose rate less than 800 MU/min.
The purpose of this study was to develop and validate EPID-based dosimetry for SRS and SRT patient-specific QA. Four parameters were included for converting the image to a planar dose at depth 10 cm; dose-response linearity with MU, beam profile correction, collimator scatter and water kernel.

2. Material and Method

TrueBeam LINACs (Varian Medical Systems, Palo Alto, CA, USA) and the aS 1000 EPID detector systems with integrated mode using Image Acquisition Systems version 3 (IAS-3) were used in this study. The radiation treatment of SRS and SRT was delivered with a 6 MV FFF beam. Eclipse TPS version 13.6 (Varian Medical Systems, Palo Alto, CA, USA) was used to calculate dose distribution. MATLAB software version 2019b (The Mathworks, Inc, Natick, MA, USA) was used to manipulate the images in the EPID-based dosimetry model.
Figure 1 shows a flowchart diagram of this study. The appropriated SID to reduce saturation effect was investigated, and then the EPID-based dosimetry model for FFF beam was developed. The accuracy of our model (the co-operation between extended SID and EPID-based model) was validated by comparing between EPID-based dosimetry measurements and planned dose calculation in clinical plans. In addition, the traditional measurements with diode arrays were used to confirm the accuracy of our EPID-based dosimetry model by performing patient-specific QA in the same clinical plans.

2.1. Appropriate SID for Reducing Saturation Effect

In this study, the appropriate SID that can reduce the saturation effect was found by comparing the radiation measurement in different SIDs from 120 to 180 cm, and the measurement was performed with different dose rates (400, 600, 800, 1000, 1200, 1400 MU/min). This experiment’s hypothesis is the radiation signal should similar when delivering the same MU in different dose rates. The standard deviation (SD) of EPID signals was used to determine the EPID saturation effect in different SIDs.

2.2. EPID-Based Dosimetry Model

Before applying the EPID-based dosimetry model to the measurement, basic image calibration was performed according to vendor recommendations [19], including darkfield, flood field, and dose normalization. The EPID-based dosimetry model was designed by converting the EPID images (EPIDx,y) to absorbed dose in the water at a depth of 10 cm (D) with four parameters as shown in Equation (1).
D = ( E P I D x , y   ×   f d o s e   ×   M F F F 2 D   ×   S f s )   1   K w a t e r

2.2.1. Dose Linearity Calibration

The first step, the relation between Calibration Units (CU) and absorbed dose at a depth of 10 cm in water (fdose), was determined for scaling CU to absorbed dose in Gy, and it can be explained as Equation (2).
fdose = A × CU + B
A is the first constant parameter for linearity function, and B is the second constant parameter for a linear function.
To find the function of linearity dose calibration, the absorbed dose in water was measured using FC65-G cylindrical ionization chamber (IBA Dosimetry GmbH, Schwarzenbruck, Germany) for various MU with the field size of 10 × 10 cm2 at a depth of 10 cm, which was related to radiation measurement from EPID in CU.

2.2.2. 2-Dimensional Beam Profile Correction

The second step, the off-axis difference between EPID and water, was assessed using the ratio between water and EPID diagonal profile at a field size of 40 × 40 cm2. A polynomial fourth order function was determined to fit the beam profile correction curve, and then the function was extracted into 2-dimensional symmetry ( M F F F 2 D ), which was explained as Equation (3).
M F F F 2 D = C x 4   +   D x 3   + E x 2   + F x + G
x is the off-axis distance in cm, whereas C, D, E, F, and G are the first, second, third, fourth, and fifth constant parameters.

2.2.3. Collimator Scatters Correction

The third step, the influence of collimator scatter difference between EPID and water was calculated using the ratio of collimator scatter response between EPID and water. A polynomial third-order function was determined to fit the collimator scatter correction curve (Sfs), which was explained as Equation (4).
Sfs = Hx3 + Ix2 + Jx + K
x is the equivalent square field size in cm × cm, whereas H, I, J, and K are the first, second, third, and fourth constant parameters.
To find the scatter correction, the collimator and phantom scatter were measured using CC01 and FC65-G cylindrical ionization chamber (IBA Dosimetry GmbH, Schwarzenbruck, Germany) at a depth of 10 cm with varying field size from 1 × 1 cm2 to 8 × 8 cm2, which were related to radiation measurement from EPID in CU. To improve the accuracy of scatter measurement by an ionization chamber, the collimator, and phantom scatter was conducted with the method of IAEA TRS 483 protocol [23].

2.2.4. Water Kernel

The fourth step, a remaining error between our model corrected with previous corrections (fdose,   M F F F 2 D , Sfs) and dose distribution in water, was reduced using the water kernel (Kwater) parameter as described by King et al. [24] method. Briefly explained here, the optimization algorithm was used to fit the water kernel (Kwater) function by minimizing disagreement between the EPID-based dosimetry profile and the ionization chamber profile. This model was predominantly used for SRS/SRT patient-specific QA, therefore; the small field profile with field sizes of 2 × 2, 3 × 3, 5 × 5, and 8 × 8 cm2 was collected for the optimization in this study. Basically, an exponential function was used to fit the water kernel (Kwater) function, which was explained as Equation (5). The water kernel function was extracted into 2-dimensional symmetry to operate with EPID images.
K w a t e r = e ( a 1 r ) + a 2 e ( a 3 r ) + a 4 e ( a 5 r )
where r is the distance from beam central-axis and a1, a2, a3, a4, a5 are the first, second, third, fourth, and fifth constant parameter, respectively.

2.3. Model Validation

Figure 2 shows the process of model validation. To assess the model accuracy, 10 SRS/SRT plans in brain lesions were randomly conducted for the patient-specific QA measurements. Table 1 shows plan information for this study. The information of collimator field size and PTV size was also addressed, as shown in Table 2. Dose agreement between EPID-based dosimetry and plane dose calculation from TPS was determined using gamma analysis with gamma criteria of 3%/3 mm, 2%/2 mm, and the cut-off threshold at 10%.
In our department, MapCHECK diode arrays (Sun Nuclear Corporation, Melbourne, FL, USA) were previously used as a QA tool; hence, dose agreement between MapCHECK measurement and plane dose calculation from TPS was also determined to confirm the result of model validation. According to the low resolution of Mapcheck detector (7.07 mm spacing for inner area), it is not enough accuracy for measurement of the small field in SRS and SRT. Therefore, the resolution of the MapCheck detector was increased by merging two measurement sets with SNC Patient software. The first measurement was performed by aligning beam isocenters to the center of MapCheck, and the second measurement was performed by aligning beam isocenter to the phantom offset at 5 mm superior with couch shift. This method can increase the detector resolution to 3.54 mm spacing for the inner area.
For dose calculation from TPS, plan data was transferred to slab water phantom (size of Height × Width × Long: 40 × 30 × 40 cm) by resetting the gantry to 0 degrees. Then the dose distribution was re-calculated using AAA (Analytical Anisotropic Algorithm) of Eclipse TPS. The dicom format of the single plane dose was exported to MATLAB software to verify the dose agreement between our EPID-based dosimetry and plane dose calculation from TPS. For EPID-based dosimetry, the image was quired with integrated mode, and then images were calculated to plane dose at a depth of 10 cm with our model.

3. Results

3.1. Appropriate SID for Reducing Saturation Effect

Table 3 shows the EPID signal in CU with varying SID and dose rates. The SD of the EPID signal was used to determine the EPID saturation effect in different SIDs. The maximum SD was found at SID of 120 cm with 3.45 SD in a measurement dose rate from 400 to 1400 MU/min. The minimum SD was found at SID of 180 cm with 0.64 SD in a measurement dose rate from 400 to 1400 MU/min. However, the increasing of SID may produce the scattered radiation with increasing the noise to EPID measurement. Hence, the SID of 150 cm was selected for patient-specific QA to compromise between reducing the saturation effect and scattered radiation.

3.2. EPID-Based Dosimetry Model

Linearity function (fdose) for EPID-based dosimetry was found as fdose = 0.008 × CU + 0.011. Figure 3 shows the relationship between CU and absorbed dose (Gy) at a depth of 10 cm.
The polynomial function of one-dimensional beam profile correction was found as 1 D   profile = 3.9 × 10 4 x 4 + 1.7 × 10 2 x 3 0.29 x 2 + 0.42 x + 100 . Then 1D profile was extracted to a 2D symmetry profile, as shown in Figure 4.
Collimator scatter correction (Sfs) was found as Sfs = −7.8 × 10−5x4 + 0.0022x3 − 0.023x2 + 0.11x + 0.75. Figure 5 shows collimator scatter correction (Sfs) plotted between radiation field size and collimator scatter correction.
Water kernel function (Kwater) was found as Kwater = e (−25∗r) + (8 × 10−4) e (−1.5∗r) + (1.7 × 10−5) e (−0.22∗r). Where r is distance from the center. Figure 6 shows water kernel (Kwater) curve for 6 X-FFF.

3.3. Model validation

Table 4 shows gamma passing rates (GPR) results of our EPID-based dosimetry and MapCHECK measurements. For EPID-based dosimetry at criteria of 3%/3 mm, lowest GPR was 98.99 ± 0.73% and highest GPR was 99.8 ± 0.39%. For EPID-based dosimetry at criteria of 2%/2 mm, lowest GPR was 95.33 ± 2.95% and highest GPR was 99.47 ± 3.12%. For MapCHECK at criteria of 3%, 3 mm, lowest GPR was 96.90 ± 1.57%, and highest GPR was 99.66 ± 2.1%. For MapCHECK of 2%, 2 mm, lowest GPR was 94.83 ± 3.03% and highest GPR was 98.61 ± 2.49%. Figure 7 shows example of planar dose distribution between EPID-based dosimetry and TPS dose calculation with gamma criteria 2%/2 mm.

4. Discussions

In this study, the saturation effect was reduced by using the extended SID method. Although SID increasing can decrease the saturation effect, the scatter radiation (noise) also increases when SID was increased [25]. Hence, the SID of 150 cm was selected as the appropriate SID for EPID measurement with a signal range between 497.18 CU (at dose rate 1400 MU/min) and 500.81 CU (at dose rate 400 MU/min), and the standard deviation (SD) of measurement was found at ±1.35 CU. The appropriated SID was found comparable to Pardo study [13], with the SID beyond 140 cm can reduce the saturation effect.
There are two approaches to reconstruct EPID-based dosimetry. The first approach, photon fluence was calculated to dose distribution at the EPID plane using a TPS or independent algorithm. Then the dose distribution at the EPID plane was compared to EPID measurement [26]. In the second approach, EPID images were calculated to the absorbed dose at the water. Then the dose estimation at the water was compared to TPS’s dose calculation [27,28]. The advantage of the second approach is the potential to directly verify the TPS algorithm’s accuracy [29]. Our EPID-based dosimetry model was also achieved as a second approach by reconstruction images to planar dose distribution in the water.
Our EPID-based dosimetry model has been published elsewhere [30] with less validated plans. Therefore, this study has the effort to implement the EPID-based dosimetry model for SRS and SRT plans, and the results demonstrated a good agreement between EPID-based dosimetry and traditional detector arrays measurement (MapCHECK).
MapCHECK measurement represents a previous patient-specific QA tool in our institute with low spatial resolution detectors (445 diodes in 22 × 22 cm2 of radiation area) compared to EPIDs with a high spatial resolution (1024 × 768 pixels in 40 × 30 cm2 of radiation area). Although the density of the detector was increased with merging between two measurement sets, the MapCheck detector resolution is still less than EPIDs. When the results of patient-specific QA using EPID-based dosimetry and MapCHECK measurements were observed, it was found that EPID-based dosimetry has better agreement than MapCHECK due to the influence of spatial resolution detectors as described by Benjamin et al. [31]. The result of our EPID-based dosimetry and MapCHECK was also compared to Miri study [12], and similar results were found.
The patient-specific QA procedure between EPID-based dosimetry and diode arrays was discussed here; patient-specific QA with diode arrays required setting a phantom and connecting the signal cable while patient-specific QA with EPID did not require them. However, EPID-based dosimetry required more frequency of dose calibration than diode arrays because the accumulated dose effect can reduce EPID signal sensitivity [32]. In this study, both QA tools were performed the dose calibration before measurement to eliminate the sensitivity degradation.
According to the image acquisition method, EPID-based dosimetry can be measured with two modes: integrated and cine mode. EPID captures a single image for integrated mode consisting of the average number of frames acquired during radiation delivery [26]. For cine mode, a sequence of multiple images is captured during radiation delivery instead of a single integrated image [33]. Since cine mode is synchronized to beam pulses, the frame acquisition rate depends on the dose rate [34]. Our study used the integrated mode to acquire the images due to a more negligible dose rate effect than the cine mode.
Backscatter form arm support was influenced to the accuracy of EPID-based dosimetry for amorphous silicon (a-Si) 1000 as described by [35]. To reduce the backscatter effect from arm support in this study, the Varian’s Preconfigured Portal Dosimetry Package (PDPC) was applied to EPID measurement with the 2D profile correction image [36].
The disadvantage of this study is the EPID-based dosimetry measurement does not include isocenter accuracy because EPID images were acquired by resetting the gantry at 0 degrees. However, the treatment isocenter accuracy was separately verified in the Winston-Lutz test.
In this study, the various clinical plan parameters such as dose prescription, arc number, target number, were included in the model validation for testing the model accuracy. However, the limitation of filed sizes from 2.6 to 6 cm2 was only validated in this study. Therefore, the field size < 2 cm2 should be concerned for this model. The GPR was found more than 98% for gamma criteria 3%/3 mm, and more than 95% for gamma criteria 2%/2 mm.
This study demonstrated the feasibility to use EPID-based dosimetry for SRS and SRT patient-specific QA. However, the commissioning and end-to-end test should be performed before clinical use with point dose measurement using ionization chamber and 2D dose distribution using detector arrays, film dosimetry, and gel dosimetry according to AAPM Medical Physics Practice Guideline 9.a [37] recommendation.
To maintain the EPID-based dosimetry accuracy, the periodic check with the other QA is recommended to track the radiation dose.

5. Conclusions

This study demonstrated the method to perform SRS and SRT patient-specific QA using EPID-based dosimetry in the FFF beam by co-operating between the extended SID method to reduce the saturation effect and estimate the planar dose distribution with in-house model. The possibility of SID that can reduce saturation effect was found at 150 cm with EPID measurement range between 497.18 to 500.81 CU, and SD of ±1.35 CU for dose rate range between 400 to 1400 MU/min. The model accuracy was validated in a range of field sizes from 2.6 to 6 cm2 and found good agreements between our model and TPS calculation with GPR more than 98% for gamma criteria 3%/3 mm, and GPR more than 95% for gamma criteria 2%/2 mm.

Author Contributions

Conceptualization, S.T. (Sangutid Thongsawad) and N.U.; methodology, S.T., T.C., and N.S. (Nipon Saiyo); software, T.C. and S.T.; validation, N.S. and T.C.; formal analysis, N.U.; investigation, S.T. and N.U.; resources, S.T.; data curation, N.S. and T.C.; writing—original draft preparation, S.T.; writing—review and editing, S.T., N.S. and N.U.; visualization, S.T.; supervision, N.U.; project administration, S.T.; funding acquisition, S.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research project is funded by Chulabhorn Royal Academy, and grant number RAA 2560/009.

Institutional Review Board Statement

This article does not contain any studies with human participants and animals performed.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chao, K.S.C.; Deasy, J.O.; Markman, J.; Haynie, J.; Perez, C.A.; Purdy, J.A.; Low, D.A. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49, 907–916. [Google Scholar] [CrossRef]
  2. Hong, L.; Alektiar, K.M.; Hunt, M.; Venkatraman, E.; Leibel, S.A. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59, 752–759. [Google Scholar] [CrossRef]
  3. Bruschi, A.; Esposito, M.; Pini, S.; Ghirelli, A.; Zatelli, G.; Russo, S. How the detector resolution affects the clinical significance of SBRT pre-treatment quality assurance results. Phys. Med. 2018, 49, 129–134. [Google Scholar] [CrossRef]
  4. Khan, M.; Heilemann, G.; Lechner, W.; Georg, D.; Berg, A.G. Basic Properties of a New Polymer Gel for 3D-Dosimetry at High Dose-Rates Typical for FFF Irradiation Based on Dithiothreitol and Methacrylic Acid (MAGADIT): Sensitivity, Range, Reproducibility, Accuracy, Dose Rate Effect and Impact of Oxygen Scavenger. Polymers 2019, 11, 1717. [Google Scholar] [CrossRef] [Green Version]
  5. Santos, T.; Ventura, T.; do Carmo Lopes, M. A review on radiochromic film dosimetry for dose verification in high energy photon beams. Radiat. Phys. Chem. 2021, 179, 109217. [Google Scholar] [CrossRef]
  6. Agazaryan, N.; Solberg, T.D.; De Marco, J.J. Patient specific quality assurance for the delivery of intensity modulated radiotherapy. J. Appl. Clin. Med. Phys. 2003, 4, 40–50. [Google Scholar] [CrossRef] [PubMed]
  7. Camilleri, J.; Mazurier, J.; Franck, D.; Dudouet, P.; Latorzeff, I.; Franceries, X. 2D EPID dose calibration for pretreatment quality control of conformal and IMRT fields: A simple and fast convolution approach. Phys. Med. Eur. J. Med. Phys. 2016, 32, 133–140. [Google Scholar] [CrossRef]
  8. Greer, P.B.; Popescu, C.C. Dosimetric properties of an amorphous silicon electronic portal imaging device for verification of dynamic intensity modulated radiation therapy. Med. Phys. 2003, 30, 1618–1627. [Google Scholar] [CrossRef] [PubMed]
  9. Nakaguchi, Y.; Araki, F.; Kouno, T.; Ono, T.; Hioki, K. Development of multi-planar dose verification by use of a flat panel EPID for intensity-modulated radiation therapy. Radiol. Phys. Technol. 2013, 6, 226–232. [Google Scholar] [CrossRef]
  10. Nicolini, G.; Fogliata, A.; Vanetti, E.; Clivio, A.; Cozzi, L. GLAaS: An absolute dose calibration algorithm for an amorphous silicon portal imager. Applications to IMRT verifications. Med. Phys. 2006, 33, 2839–2851. [Google Scholar] [CrossRef]
  11. Wendling, M.; McDermott, L.N.; Mans, A.; Sonke, J.J.; van Herk, M.; Mijnheer, B.J. A simple backprojection algorithm for 3D in vivo EPID dosimetry of IMRT treatments. Med. Phys. 2009, 36, 3310–3321. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Miri, N.; Keller, P.; Zwan, B.J.; Greer, P. EPID-based dosimetry to verify IMRT planar dose distribution for the aS1200 EPID and FFF beams. J. Appl. Clin. Med. Phys. 2016, 17, 292–304. [Google Scholar] [CrossRef]
  13. Pardo, E.; Novais, J.C.; Molina López, M.Y.; Ruiz Maqueda, S. On flattening filter-free portal dosimetry. J. Appl. Clin. Med. Phys. 2016, 17, 132–145. [Google Scholar] [CrossRef] [Green Version]
  14. Podesta, M.; Nijsten, S.M.; Persoon, L.C.; Scheib, S.G.; Baltes, C.; Verhaegen, F. Time dependent pre-treatment EPID dosimetry for standard and FFF VMAT. Phys. Med. Biol. 2014, 59, 4749–4768. [Google Scholar] [CrossRef]
  15. Xu, Z.; Kim, J.; Han, J.; Hsia, A.T.; Ryu, S. Dose rate response of Digital Megavolt Imager detector for flattening filter-free beams. J. Appl. Clin. Med. Phys. 2018, 19, 141–147. [Google Scholar] [CrossRef] [PubMed]
  16. Lai, Y.; Chen, S.; Xu, C.; Shi, L.; Fu, L.; Ha, H.; Lin, Q.; Zhang, Z. Dosimetric superiority of flattening filter free beams for single-fraction stereotactic radiosurgery in single brain metastasis. Oncotarget 2017, 8, 35272–35279. [Google Scholar] [CrossRef] [Green Version]
  17. Prendergast, B.M.; Popple, R.A.; Clark, G.M.; Spencer, S.A.; Guthrie, B.; Markert, J.; Fiveash, J.B. Improved clinical efficiency in CNS stereotactic radiosurgery using a flattening filter free linear accelerator. J. Radiosurg. SBRT 2011, 1, 117–122. [Google Scholar] [CrossRef] [PubMed]
  18. Xiao, Y.; Kry, S.F.; Popple, R.; Yorke, E.; Papanikolaou, N.; Stathakis, S.; Xia, P.; Huq, S.; Bayouth, J.; Galvin, J.; et al. Flattening filter-free accelerators: A report from the AAPM Therapy Emerging Technology Assessment Work Group. J. Appl. Clin. Med. Phys. 2015, 16, 12–29. [Google Scholar] [CrossRef]
  19. Varian Medical Systems. Beam Cofiguration Reference Guide; Varian Medical Systems: Palo Alto, CA, USA, 2017. [Google Scholar]
  20. Tyner, E.; McClean, B.; McCavana, P.; af Wetterstedt, S. Experimental investigation of the response of an a-Si EPID to an unflattened photon beam from an Elekta Precise linear accelerator. Med. Phys. 2009, 36, 1318–1329. [Google Scholar] [CrossRef]
  21. Nicolini, G.; Clivio, A.; Vanetti, E.; Krauss, H.; Fenoglietto, P.; Cozzi, L.; Fogliata, A. Evaluation of an aSi-EPID with flattening filter free beams: Applicability to the GLAaS algorithm for portal dosimetry and first experience for pretreatment QA of RapidArc. Med. Phys. 2013, 40, 111719. [Google Scholar] [CrossRef]
  22. Chuter, R.W.; Rixham, P.A.; Weston, S.J.; Cosgrove, V.P. Feasibility of portal dosimetry for flattening filter-free radiotherapy. J. Appl. Clin. Med. Phys. 2016, 17, 112–120. [Google Scholar] [CrossRef] [Green Version]
  23. Palmans, H.; Andreo, P.; Huq, M.S.; Seuntjens, J.; Christaki, K.E.; Meghzifene, A. Dosimetry of small static fields used in external photon beam radiotherapy: Summary of TRS-483, the IAEA–AAPM international Code of Practice for reference and relative dose determination. Med. Phys. 2018, 45, e1123–e1145. [Google Scholar] [CrossRef] [Green Version]
  24. King, B.W.; Greer, P.B. A method for removing arm backscatter from EPID images. Med. Phys. 2013, 40, 071703. [Google Scholar] [CrossRef]
  25. Chen, H.; Rottmann, J.; Yip, S.S.; Morf, D.; Füglistaller, R.; Star-Lack, J.; Zentai, G.; Berbeco, R. Super-resolution imaging in a multiple layer EPID. Biomed. Phys. Eng. Express 2017, 3, 025004. [Google Scholar] [CrossRef] [Green Version]
  26. Bawazeer, O.; Herath, S.; Sarasanandarajah, S.; Kron, T.; Deb, P. The Influence of Acquisition Mode on the Dosimetric Performance of an Amorphous Silicon Electronic Portal Imaging Device. J. Med. Phys. 2017, 42, 90–95. [Google Scholar] [CrossRef]
  27. Boutry, C.; Sors, A.; Fontaine, J.; Delaby, N.; Delpon, G. Technical Note: A simple algorithm to convert EPID gray values into absorbed dose to water without prior knowledge. Med. Phys. 2017, 44, 6647–6653. [Google Scholar] [CrossRef]
  28. Zwan, B.J.; King, B.W.; O’Connor, D.J.; Greer, P.B. Dose-to-water conversion for the backscatter-shielded EPID: A frame-based method to correct for EPID energy response to MLC transmitted radiation. Med. Phys. 2014, 41, 081716. [Google Scholar] [CrossRef] [PubMed]
  29. Boellaard, R.; Essers, M.; van Herk, M.; Mijnheer, B.J. New method to obtain the midplane dose using portal in vivo dosimetry. Int. J. Radiat. Oncol. Biol. Phys. 1998, 41, 465–474. [Google Scholar] [CrossRef]
  30. Thongsawad, S.; Chanton, T.; Saiyo, N.; Udee, N. Development of EPID-based dosimetry for FFF-beam verification in radiation therapy. J. Phys. Conf. Ser. 2019, 1285, 012031. [Google Scholar] [CrossRef]
  31. Nelms, B.E.; Zhen, H.; Tome, W.A. Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors. Med. Phys. 2011, 38, 1037–1044. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Winkler, P.; Hefner, A.; Georg, D. Dose-response characteristics of an amorphous silicon EPID. Med. Phys. 2005, 32, 3095–3105. [Google Scholar] [CrossRef]
  33. McCurdy, B.M.; Greer, P.B. Dosimetric properties of an amorphous-silicon EPID used in continuous acquisition mode for application to dynamic and arc IMRT. Med. Phys. 2009, 36, 3028–3039. [Google Scholar] [CrossRef] [PubMed]
  34. Yeo, I.J.; Jung, J.W.; Patyal, B.; Mandapaka, A.; Yi, B.Y.; Kim, J.O. Conditions for reliable time-resolved dosimetry of electronic portal imaging devices for fixed-gantry IMRT and VMAT. Med. Phys. 2013, 40, 072102. [Google Scholar] [CrossRef] [Green Version]
  35. Rowshanfarzad, P.; McCurdy, B.M.; Sabet, M.; Lee, C.; O’Connor, D.J.; Greer, P.B. Measurement and modeling of the effect of support arm backscatter on dosimetry with a varian EPID. Med. Phys. 2010, 37, 2269–2278. [Google Scholar] [CrossRef] [PubMed]
  36. Esch, A.V.; Huyskens, D.P.; Hirschi, L.; Scheib, S.; Baltes, C. Optimized Varian aSi portal dosimetry: Development of datasets for collective use. J. Appl. Clin. Med. Phys. 2013, 14, 82–99. [Google Scholar] [CrossRef] [PubMed]
  37. Halvorsen, P.H.; Cirino, E.; Das, I.J.; Garrett, J.A.; Yang, J.; Yin, F.-F.; Fairobent, L.A. AAPM-RSS Medical Physics Practice Guideline 9.a. for SRS-SBRT. J. Appl. Clin. Med. Phys. 2017, 18, 10–21. [Google Scholar] [CrossRef]
Figure 1. Flowchart diagram of this study.
Figure 1. Flowchart diagram of this study.
Life 11 01159 g001
Figure 2. The process of model validation.
Figure 2. The process of model validation.
Life 11 01159 g002
Figure 3. The relationship between CU and absorbed dose (Gy) at a depth of 10 cm.
Figure 3. The relationship between CU and absorbed dose (Gy) at a depth of 10 cm.
Life 11 01159 g003
Figure 4. 2D symmetry profile of this model.
Figure 4. 2D symmetry profile of this model.
Life 11 01159 g004
Figure 5. Collimator scatter correction (Sfs), EPID collimator scatter (Sc,p EPID), and water collimator scatter (Sc,p water).
Figure 5. Collimator scatter correction (Sfs), EPID collimator scatter (Sc,p EPID), and water collimator scatter (Sc,p water).
Life 11 01159 g005
Figure 6. Water kernel (Kwater) of EPID for 6 X-FFF.
Figure 6. Water kernel (Kwater) of EPID for 6 X-FFF.
Life 11 01159 g006
Figure 7. Example of planar dose distribution between EPID-based dosimetry and TPS dose calculation with gamma criteria 2%/2 mm, (a) EPID planar dosimetry of plan No.1, (b) gamma index of plan No.1, (c) TPS planar dose of plan No.1, (d) EPID planar dosimetry of plan No.2, (e) Gamma index of plan No.2, and (f) TPS planar dose of plan No.2.
Figure 7. Example of planar dose distribution between EPID-based dosimetry and TPS dose calculation with gamma criteria 2%/2 mm, (a) EPID planar dosimetry of plan No.1, (b) gamma index of plan No.1, (c) TPS planar dose of plan No.1, (d) EPID planar dosimetry of plan No.2, (e) Gamma index of plan No.2, and (f) TPS planar dose of plan No.2.
Life 11 01159 g007
Table 1. Information of model validation plans.
Table 1. Information of model validation plans.
Plan ParametersInformation (n = Number of Plan)
Dose prescription6 Gy × 5 fractions (2 plans), 5 Gy × 5 fractions (2 plans), 24 Gy × 1 fraction (2 plans), 18 Gy × 1 fraction (2 plans), 12 Gy × 1 fraction (2 plans)
Arc numbers3 full arcs (3 plans), 3 full arcs + 2 partial arcs (3 plans), 5 partial arcs (2 plans), 3 full arcs + 2 partial arcs (2 plans)
Target numbers2 targets (2 plans), 1 target (8 plans)
Table 2. The collimator filed size and PTV size of plan validation.
Table 2. The collimator filed size and PTV size of plan validation.
PlanField Size (cm)PTV Geometry
X-JawsY-JawsVolume (cm3)Equivalent Sphere Diameter (cm)
Plan No.15.28 ± 0.2365.5 ± 030.313.9
Plan No.24.46 ± 0.1155 ± 0.28915.553.1
Plan No.32.92 ± 0.0843.02 ± 0.0454.462
Plan No.43.8 ± 0.0824.1 ± 0.14115.083.1
Plan No.5 *2.58 ± 0.2062.55 ± 0.2381.33, 2.781.4, 1.7
Plan No.64.3 ± 03.9 ± 013.863
Plan No.76 ± 05.8 ± 028.863.8
Plan No.84.9 ± 0.1645.67 ± 0.41817.93.2
Plan No.93.28 ± 0.0963.25 ± 0.1295.52.2
Plan No.10 *4.15 ± 0.1734 ± 019.72, 5.773.4, 2.2
Mean ± SD4.06 ± 1.0234.2 ± 1.12413.43 ± 9.7792.75 ± 0.823
* The patient was treated with two targets.
Table 3. The EPID signal in CU with varying SID and dose rates.
Table 3. The EPID signal in CU with varying SID and dose rates.
SID
(cm)
CU in Different Dose Rates
1400 MU/min1200 MU/min1000 MU/min800 MU/min600 MU/min400 MU/minAverageSD
120765.26765.51768.61770.10772.14773.76769.233.45
130655.66656.27657.59659.10660.32661.09658.342.19
140567.53568.59569.72570.86571.63572.38570.121.85
150497.18498.20499.05499.62500.32500.81499.201.35
160439.42440.20440.75441.19441.81442.16440.921.20
170391.38391.92392.30392.81393.18393.53392.520.81
180351.14351.52351.89352.17352.26352.85352.020.64
Table 4. Results of GPR of our EPID-based dosimetry and MapCHECK measurements.
Table 4. Results of GPR of our EPID-based dosimetry and MapCHECK measurements.
PlanGPR
(Mean ± SD)
EPID-Based DosimetryMapCHECK
3%/3 mm2%/2 mm3%/3 mm2%/2 mm
Plan No.199.50 ± 0.3497.38 ± 2.7799.12 ± 1.8596.45 ± 2.55
Plan No.299.32 ± 0.9599.47 ± 3.1298.85 ± 1.1597.88 ± 2.39
Plan No.399.47 ± 0.6398.36 ± 1.3996.90 ± 1.5794.83 ± 3.03
Plan No.499.19 ± 0.5295.33 ± 2.9598.75 ± 1.7198.17 ± 2.63
Plan No.599.05 ± 0.6398.42 ± 2.6799.66 ± 2.198.61 ± 2.49
Plan No.699.8 ± 0.3998.67 ± 1.8699.42 ± 1.4395.60 ± 3.37
Plan No.799.57 ± 0.5998.24 ± 2.3098.67 ± 2.3196.37 ± 3.89
Plan No.899.77 ± 0.599.19 ± 2.6997.64 ± 1.8895.50 ± 3.91
Plan No.998.99 ± 0.7395.55 ± 3.4297.99 ± 2.1496.45 ± 2.41
Plan No.1099.18 ± 0.7297.56 ± 2.6598.67 ± 1.3498.51 ± 2.75
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Thongsawad, S.; Chanton, T.; Saiyo, N.; Udee, N. Planar EPID-Based Dosimetry for SRS and SRT Patient-Specific QA. Life 2021, 11, 1159. https://doi.org/10.3390/life11111159

AMA Style

Thongsawad S, Chanton T, Saiyo N, Udee N. Planar EPID-Based Dosimetry for SRS and SRT Patient-Specific QA. Life. 2021; 11(11):1159. https://doi.org/10.3390/life11111159

Chicago/Turabian Style

Thongsawad, Sangutid, Tadchapong Chanton, Nipon Saiyo, and Nuntawat Udee. 2021. "Planar EPID-Based Dosimetry for SRS and SRT Patient-Specific QA" Life 11, no. 11: 1159. https://doi.org/10.3390/life11111159

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop